Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 3
Max Chain Length: 4
Degree Type: Indegree
Preference: CY
Time Taken: 0.011014
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	
Cycle 3:	15	13	1	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.005566
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.009744
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.009897
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.010039
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.010246
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.013908
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.012923
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.020341
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.014681
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.015532
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.01765
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.015656
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.02048
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.016706
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.013533
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.015365
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.0124
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
Instance: KP_Num2_N16_A0.txt
Max Cyle Length: 6
Max Chain Length: 6
Degree Type: Indegree
Preference: CY
Time Taken: 0.01665
Time Limit: 15
Status: Optimal
Objective Value: 8
Cycle 1:	9	4	
Cycle 2:	11	2	3	1	
Cycle 3:	15	13	

Average Chain Length: nan
Average Cycle Length: 2.66667
Percentage of highly-sensitized patients in solution (%): 0
